HK$23.98
2.92%
Hong Kong, Sep 25, 03:45 pm HKT. Closed.
ISIN
KYG3887G1091
Symbol
2367

Giant Biogene Holding Co Target price 2026 - Analyst rating & recommendation

Giant Biogene Holding Co Classifications & Recommendation

Buy
82%
Hold
18%

Giant Biogene Holding Co Price Target

Target Price HK$39.17
Price HK$24.70
Potential
Number of Estimates 17
17 Analysts have issued a price target Giant Biogene Holding Co 2027 . The average Giant Biogene Holding Co target price is HK$39.17. This is higher than the current stock price. The highest price target is
HK$77.41 213.38%
register free of charge
, the lowest is .
A rating was issued by 28 analysts: 23 Analysts recommend Giant Biogene Holding Co to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Giant Biogene Holding Co stock has an average upside potential 2027 of . Most analysts recommend the Giant Biogene Holding Co stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion HK$ 6.45 7.32
0.37% 13.49%
EBITDA Margin 40.23% 36.31%
5.56% 9.75%
Net Margin 34.70% 31.55%
6.81% 9.07%

22 Analysts have issued a sales forecast Giant Biogene Holding Co 2026 . The average Giant Biogene Holding Co sales estimate is

HK$7.3b
unlock
. This is
17.65% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HK$9.4b 50.63%
unlock
, the lowest is
HK$6.7b 7.79%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$6.4b 0.37%
2026
HK$7.3b 13.49%
unlock
2027
HK$8.1b 10.99%
unlock
2028
HK$9.1b 11.77%
unlock
2029
HK$15.1b 66.46%
unlock
2030
HK$17.5b 15.54%
unlock

21 Giant Biogene Holding Co Analysts have issued a net profit forecast 2026. The average Giant Biogene Holding Co net profit estimate is

HK$2.3b
unlock
. This is
18.14% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HK$2.5b 29.31%
unlock
, the lowest is
HK$2.1b 7.13%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$2.2b 7.15%
2026
HK$2.3b 3.18%
unlock
2027
HK$2.5b 9.18%
unlock
2028
HK$2.8b 10.24%
unlock

Net Margin

2025 34.70% 6.81%
2026
31.55% 9.07%
unlock
2027
31.03% 1.65%
unlock
2028
30.61% 1.35%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share HK$ 2.11 2.17
12.45% 2.84%
P/E 11.36
EV/Sales 2.31

21 Analysts have issued a Giant Biogene Holding Co forecast for earnings per share. The average Giant Biogene Holding Co EPS is

HK$2.17
unlock
. This is
17.93% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HK$2.38 29.35%
unlock
, the lowest is
HK$1.97 7.07%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$2.11 12.45%
2026
HK$2.17 2.84%
unlock
2027
HK$2.37 9.22%
unlock
2028
HK$2.62 10.55%
unlock

P/E ratio

Current 13.42 48.19%
2026
11.36 15.37%
unlock
2027
10.40 8.45%
unlock
2028
9.44 9.23%
unlock

Based on analysts' sales estimates for 2026, the Giant Biogene Holding Co stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.72
2026
2.31 15.15%
unlock
2027
2.08 9.90%
unlock
2028
1.86 10.53%
unlock
2029
1.12 39.92%
unlock
2030
0.97 13.46%
unlock

P/S ratio

Current
2026
3.49 15.00%
unlock
2027
3.14 9.90%
unlock
2028
2.81 10.53%
unlock
2029
1.69 39.93%
unlock
2030
1.46 13.45%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today